top of page
Backgrounds.jpg

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merus N.V. - Common Shares (NQ:MRUS)

90.00 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merus N.V. - Common Shares

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Merus Appoints Life Sciences Strategic and Financial Industry Veteran Greg Perry as Chief Financial Officer
From Merus N.V.
Via GlobeNewswire
News headline image
Merus to Participate in a Fireside Chat at the Jefferies Healthcare Conference 2023
From Merus N.V.
Via GlobeNewswire
News headline image
7 Stocks That Wall Street Analysts Are Loving in May ↗
Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love. 
Via InvestorPlace
News headline image
Where Merus Stands With Analysts ↗
 
Via Benzinga
News headline image
Recap: Merus Q1 Earnings ↗
 
Via Benzinga
News headline image
Analyst Boosts Merus Price Target As AACR Updates Meaningfully De-Risk Its Head & Cancer Therapy ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Merus ↗
 
Via Benzinga
News headline image
Merus Announces Financial Results for the First Quarter 2023 and Provides Business Update
From Merus N.V.
Via GlobeNewswire
News headline image
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional... 
Via Benzinga
News headline image
4 Analysts Have This to Say About Merus ↗
 
Via Benzinga
Merus Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
5 Analysts Have This to Say About Merus ↗
 
Via Benzinga
News headline image
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Merus’ Petosemtamab Interim Data Demonstrates Clinically Meaningful Activity in Previously Treated Head and Neck Squamous Cell Carcinoma (HNSCC)
From Merus N.V.
Via GlobeNewswire
News headline image
Merus' Petosemtamab Abstract Hits Upside Scenario For Overall Response Rate, Duration Of Response: Analyst ↗
 
Via Benzinga
News headline image
Merus Announces Publication of an Abstract on Petosemtamab in Advanced Gastric/Esophageal Adenocarcinoma for Presentation at the AACR Annual Meeting 2023
From Merus N.V.
Via GlobeNewswire
News headline image
Merus Announces Publication of an Abstract on Petosemtamab Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma for Plenary Session Oral Presentation at the AACR Annual Meeting 2023 and Provides a Program and Regulatory Update
From Merus N.V.
Via GlobeNewswire
News headline image
What To Expect When Merus Presents Petosemtamab Data Update At AACR ↗
 
Via Benzinga
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
News headline image
Merus Announces Publication of an Abstract on Preclinical Mechanism of Action of MCLA-129 Selected for Poster Presentation at the AACR Annual Meeting 2023
Poster presentation: Tuesday, April 18, 2023, 1:30-5:30 p.m. ET 
From Merus N.V.
Via GlobeNewswire
News headline image
Merus Announces Petosemtamab in Previously Treated Head and Neck Squamous Cell Carcinoma Abstract Selected for Plenary Session Oral Presentation at the AACR Annual Meeting 2023
From Merus N.V.
Via GlobeNewswire
News headline image
Merus Announces Financial Results for the Fourth Quarter and Full Year 2022 and Provides Business Update
From Merus N.V.
Via GlobeNewswire
News headline image
MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday. 
Via Benzinga
News headline image
Merus to Participate in Upcoming Investor Conferences
From Merus N.V.
Via GlobeNewswire
News headline image
CORRECTING and REPLACING --Merus Provides 2023 Outlook
From Merus N.V.
Via GlobeNewswire
News headline image
Merus Provides 2023 Outlook
From Merus N.V.
Via GlobeNewswire
News headline image
Merus to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference
From Merus N.V.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗
 
Via Benzinga
News headline image
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday ↗
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page